Camille Sebaaly
Director of Finance/CFO at SUNSHINE BIOPHARMA, INC.
Net worth: 10 468 $ as of 31/03/2024
Profile
Camille Sebaaly is the founder of Advanomics Corp.
He is currently working as the Chief Financial Officer & Secretary at Sunshine Biopharma, Inc. since 2021.
Previously, he worked as the Chief Financial Officer & Secretary at Mountain West Business Solutions, Inc. in 2009 and at Sunshine Biopharma, Inc. in 2009.
Mr. Sebaaly completed his undergraduate degree from The State University of New York in 1987.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
28/03/2024 | 174,465 ( 0.18% ) | 10 468 $ | 31/03/2024 |
Camille Sebaaly active positions
Companies | Position | Start |
---|---|---|
SUNSHINE BIOPHARMA, INC. | Director of Finance/CFO | 15/10/2009 |
Former positions of Camille Sebaaly
Companies | Position | End |
---|---|---|
Sunshine Biopharma, Inc. /Old/ | Director of Finance/CFO | 25/11/2009 |
Mountain West Business Solutions, Inc. | Director of Finance/CFO | 25/11/2009 |
Advanomics Corp.
Advanomics Corp. BiotechnologyHealth Technology Advanomics Corp. is a Canadian company that focuses on researching and developing treatments for cancer and other human diseases. The private company is based in Montréal, Canada. and has subsidiaries in Canada. The company was founded by Steve N. Slilaty and Camille Sebaaly. | Founder | - |
Training of Camille Sebaaly
The State University of New York | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SUNSHINE BIOPHARMA, INC. | Health Technology |
Private companies | 3 |
---|---|
Mountain West Business Solutions, Inc. | Commercial Services |
Sunshine Biopharma, Inc. /Old/ | Commercial Services |
Advanomics Corp.
Advanomics Corp. BiotechnologyHealth Technology Advanomics Corp. is a Canadian company that focuses on researching and developing treatments for cancer and other human diseases. The private company is based in Montréal, Canada. and has subsidiaries in Canada. The company was founded by Steve N. Slilaty and Camille Sebaaly. | Health Technology |
- Stock Market
- Insiders
- Camille Sebaaly